MarketLens MarketLens
US: 2026-06-12 NSE: 2026-06-12 2026-06-14
Negative
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

ALNY Alnylam Pharmaceuticals, Inc.

TradingView As Of 6/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
283.5850
Day %
-2.72%
RS
11
RS 1D
12
RS 1W
14
RS 1M
18
RS 3M
25
RS 6M
70
Consensus Rating
Buy
Current Quarter EPS
1.00
Next Quarter EPS
1.37
Current Year EPS
6.68
Next Year EPS
10.61
ExchangeUS
Market Cap42 B
52W High495.5500
From 52W High-42.77%
Open288.9600
High291.2800
Low281.7650
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-06-12
Bars Available309
Scanner Hits1
Last Scanner Hit2026-06-09

Recent Scanner History

1 matching / 1 total
Reset
Date Scanner RS
2026-06-09 Showing Strength
SHOWING_STRENGTH_US
14

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy 1.00 1.37 6.68 10.61
Based on 26 analysts offering recommendations for 'ALNY'.

Quarterly EPS Forecasts

5 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 1.00 1.67 0.64 8
0 0
Jun 2026 1.37 1.86 0.71 6
0 0
Sep 2026 1.74 2.38 1.24 6
0 0
Dec 2026 1.87 3.33 -0.02 6
0 0
Mar 2027 2.58 2.58 2.58 1
0 0

Yearly EPS Forecasts

4 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 6.68 9.48 4.89 13
0 1
Dec 2027 10.61 14.99 7.75 11
0 1
Dec 2028 13.71 17.37 11.08 6
0 1
Dec 2029 14.89 18.79 12.21 4
0 2